K163617

Substantially Equivalent

REMbrandt

Applicant: Embla Systems
Product code: OLZ
Advisory panel: Neurology
Date received: 2016-12-22
Decision date: 2017-04-11
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Kanata, CA

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.